Join our community of smart investors

Neil Woodford's new investments, scope for dividend growth, avoiding fossil fuels and passive fund closures

A round-up of this week's fund stories
May 18, 2017

Neil Woodford has sold GlaxoSmithKline (GSK), in which he has invested for more than 15 years, out of CF Woodford Equity Income fund (GB00BLRZQB71) and reinvested in cyclical stocks and a bank – an area he has hardly touched for nearly as long. We look at why he has conviction in these areas of the market and banks, and find out which shares he has added to the fund.

OTHER STORIES IN THIS ISSUE

This week's tip highlights a fund which offers an attractive yield and the potential for growth over the long-term. It is run by an experienced manager, and invests in a region where dividend payouts have lagged behind earnings meaning there is plenty of scope for them to grow.

Asset manager BMO is to exclude companies with fossil fuel reserves from its Responsible funds meaning that they will have to divest some of their holdings, including a UK-listed resources company with a high yield. Personal finance writer Emma Agyemang finds out why they are doing this and which funds it will affect, and looks at some of the difficulties in finding an ethical investment that meets your requirements.

Exchange traded fund (ETF) provider Source is being taken over by its much larger US peer Invesco and two of its funds, which are similar to ones offered by its acquirer, are to close. Deputy personal finance editor Kate Beioley looks at how the funds compare and why they are closing, as well as the reasons for the merger and what it might mean for investors in these companies' other funds.

In our latest podcast Kate Beioley and Emma Agyemang look at why investment trust initial public offerings are back in fashion, and explain why ethical funds might pay higher income than you'd expect and generate healthy returns. They also highlight some ways to beat the miserly rates available on cash. They are joined by Andrew Summers, head of fund research at Investec Wealth.

Our podcast is now available across five different distribution channels to allow you to access it in the most convenient way. Find us on Soundcloud, Acast, Audioboom, Stitcher and iTunes.

This week's Portfolio Clinic features an investor who might be made redundant so wants to boost his savings and retirement funds. Our experts explain why it is important for him to hold some lower risk assets, and suggest some ways to better balance his portfolio of funds and investment trusts.

Do you have a personal finance problem? Or want to know more about something in this week's personal finance pages? If so let us know by getting in touch with leonora.walters@ft.com, kate.beioley@ft.com or emma.agyemang@ft.com.